摘要
背景:尽管阿尔茨海默病(AD)是一种神经变性病理学特征,其特征在于脑水平上β-淀粉样蛋白斑块和神经原纤维缠结的积累,但最近的研究表明,AD可能是许多改变的生理过程在整个生物体水平发生的结果。通过“弯曲”而不是“打破”适应压力的能力可以被认为是“弹性”。个体倾向于抵抗这种病理生理挑战,可以认为比那些不具有这些挑战的人更有弹性。值得注意的是,最近的文献提供了AD运动诱发的积极效应的证据,包括改善脑可塑性,增加肾上腺敏感性,增加血管健康,改善一氧化氮生物利用度和线粒体功能。本综述探讨了AD环境中的恢复力意味着什么以及身体活动可能会调解增强韧性的积极适应过程的生理机制。 方法:进行综合的PubMed搜索,以确定关于运动在AD弹性中的作用的研究。应用以下术语:阿尔茨海默病弹性,脑回弹力,代谢弹性,心血管恢复力,线粒体弹性和运动弹性。 结果:纳入73项研究。五篇论文定义了阿尔茨海默病的弹性,15篇论文的脑回弹力,5个心血管复原力,1个代谢弹性,11个线粒体弹性和7个运动弹性。其他二十六份文件从作者知识参考清单中确定。 结论:知道脑,神经内分泌,血管和线粒体代谢紊乱是神经退行性疾病和痴呆发育中的重要事件,运动诱发适应性机制的能力可能是改善AD抵抗能力的重要非药理学策略。
关键词: 阿尔茨海默病,运动,脑弹性,神经内分泌恢复力,心血管弹性,线粒体弹性。
Current Alzheimer Research
Title:Resilience to Alzheimer's Disease: The Role of Physical Activity
Volume: 14 Issue: 5
关键词: 阿尔茨海默病,运动,脑弹性,神经内分泌恢复力,心血管弹性,线粒体弹性。
摘要: Background: Although Alzheimer’s disease (AD) is a neurodegenerative pathology characterized by accumulation of β-amyloid plaques and neurofibrillary tangles at cerebral level, recent studies highlighted that AD might be the result of many altered physiological processes occurring at whole-organism level. The ability to adapt to stressors by “bending” but not “breaking” can be considered as “resilience”. Individuals incline to withstand such pathophysiological challenges, can be considered more resilient than those that do not. Noticeably, recent literature provide evidence of several exercise-induced positive effects in AD patients including improved brain plasticity, increased adrenal sensitivity, increased vascular health, ameliorations of nitric oxide bioavailability and mitochondrial function. This review explores what resilience means in the AD milieu and the physiological mechanisms by which physical activity may mediate positive adaptative processes that enhance resilience.
Methods: A comprehensive PubMed search was conducted to identify studies about the role of exercise in AD resiliency. The following terminology was applied: Alzheimer resilience, brain resilience, metabolic resilience, cardiovascular resilience, mitochondrial resilience and exercise resilience. Results: Seventy-three studies were included. Five papers defined Alzheimer’s resilience, 15 papers brain resilience, 5 cardiovascular resilience, 1 metabolic resilience, 11 mitochondrial resilience, and 7 exercise resilience. Other twenty-six paper were identified from reference list of authors’ knowledge. Conclusion: Knowing that disturbances in brain, neuroendocrine, vascular and mitochondria metabolism are important events in neurodegeneration and dementia development, the ability of exercise to trigger adaptive mechanisms might represent an important non-pharmacological strategy to improve resilience to AD.Export Options
About this article
Cite this article as:
Resilience to Alzheimer's Disease: The Role of Physical Activity, Current Alzheimer Research 2017; 14 (5) . https://dx.doi.org/10.2174/1567205014666170111145817
DOI https://dx.doi.org/10.2174/1567205014666170111145817 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes
Current Neurovascular Research Development and Potential Utility of Dual and Triple NK Receptor Antagonists
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Phytochemicals for Human Diseases: An Update)
Current Pharmaceutical Biotechnology Synaptic Dysfunction in Synucleinopathies
CNS & Neurological Disorders - Drug Targets Non-Analgesic Effects of Opioids: Opioid-induced Nausea and Vomiting: Mechanisms and Strategies for their Limitation
Current Pharmaceutical Design Attitudinal & Knowledge Barriers Towards Effective Pain Assessment & Management in Dementia: A Narrative Synthesis
Current Alzheimer Research Arundic Acid (ONO-2506) Ameliorates Delayed Ischemic Brain Damage by Preventing Astrocytic Overproduction of S100B
Current Drug Targets - CNS & Neurological Disorders Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies
Current Diabetes Reviews Laminin and its Related Peptides for the Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Enhancing the Delivery of Anti Retroviral Drug “Saquinavir” Across the Blood Brain Barrier Using Nanoparticles
Current HIV Research Optimizing ADAS-Cog Worksheets: A Survey of Clinical Trial Rater s’ Perceptions
Current Alzheimer Research Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
CNS & Neurological Disorders - Drug Targets Mechanisms for Antiplatelet Action of Statins
Current Drug Targets - Cardiovascular & Hematological Disorders The Pulse of Drug Development for Alzheimers Disease
Reviews on Recent Clinical Trials Moderate Hyperhomocysteinemia and Immune Activation
Current Pharmaceutical Biotechnology Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs
Current Medicinal Chemistry 5-HT3 Receptors
Current Drug Targets - CNS & Neurological Disorders Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets